Finnrick - Ensuring a Safer and More Transparent Supply Chain
Shenzhen Jiechuang Trading

Shenzhen Jiechuang Trading

Tirzepatide

Finnrick tested 5 samples of Tirzepatide (GLP-1 and GIP agonist) from Shenzhen Jiechuang Trading between 11 Jun 2025 and 6 Nov 2025. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).

Finnrick Rating™
Tentative Rating
Shenzhen Jiechuang Trading
Tirzepatide
Tested 5 Samples
Last test 6 Nov 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Shenzhen Jiechuang Trading

Samples are tested in commercial labs

Tests Count

5

Scores

AVG5.7MIN4.9MAX7.2

Last

6 Nov 2025

First

11 Jun 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
6 Nov 2025View7.230mg32.100mg+7.0%99.85%(no batch ID)No Label / Black Crimp / Pink CapLab EPublic
1 Oct 2025View5.045mg54.600mg+21.3%99.90%(no batch ID)(no data)Lab GPublic
1 Oct 2025View4.930mg35.700mg+19.0%99.80%(no batch ID)(no data)Lab GPublic
13 Jun 2025View4.945mg32.320mg-28.2%99.92%(no batch ID)No Label / Silver Crimp / Clear Red CapLab FPublic
11 Jun 2025View6.720mg18.300mg-8.5%99.82%(no batch ID)No Label / Silver Crimp / Blue CapLab EPublic